Milestone Pharmaceuticalsincis A Biopharmaceutical Company Focused On Innovative Cardiovascular Therapies For Acute Episodic Conditions That Require Quick Intervention Outside Of Clinical Settingsthe Company Was Founded By Experienced Leaders In Pharmaceutical Research And Developmentwith An Average Of 30 Years In Drug Development One Of Its Key Products Is Etripamila Non Dihydropyridine Calcium Channel Blocker Nasal Spray That Is Being Investigated For At Home Usethis Treatment Is Designed To Rapidly Terminate Episodes Of Paroxysmal Supraventricular Tachycardiapsvtand Atrial Fibrillation With Rapid Ventricular Rateafib Rvr Aiming To Reduce The Need For Emergency Department Visitsmilestone S Pipeline Also Includes Therapies For Other Episodic Cardiovascular Conditionsemphasizing Portability And Patient Autonomythe Company Is Dedicated To Empowering Patients To Manage Their Acute Cardiac Episodes Independently
No conferences found for this company.
| Company Name | Milestone Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
